BridgeBio Pharma Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BBIO Nasdaq 2834 http://bridgebio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BridgeBio Pharma Inc

Ivy Brain Tumor Center and BridgeBio Subsidiary QED Therapeutics Announce Collaboration to Advance Cancer Research and Treatment Options - Sep 24th, 2019 11:00 am
BridgeBio Pharma’s Origin Biosciences Presents New Data on the Natural History of Molybdenum Cofactor Deficiency (MoCD) Type A at the Society of the Study of Inborn Errors of Metabolism (SSIEM) Conference - Sep 5th, 2019 8:00 pm
3 New Biotech Stocks That Keep On Soaring - Aug 30th, 2019 1:16 am
2 New Healthcare Stocks That Wall Street Thinks You Should Buy - Jul 27th, 2019 5:01 pm
Andreas Halvorsen Widens Position in Health Care Space With BridgeBio Pharma - Jul 2nd, 2019 5:48 pm
Recent IPOs show investor appetite is strong for biotechs - Jun 28th, 2019 7:14 pm
BridgeBio Pharma Opens Above IPO Price - Jun 27th, 2019 3:12 pm
BridgeBio Pharma Announces Pricing of Its Initial Public Offering - Jun 27th, 2019 3:23 am